Get Adobe Flash player

DIABETES

AN UNPRECEDENTED INITIATIVE

WITH VERILY (FORMERLY GOOGLE LIFE SCIENCE)

Diabetes is already a global pandemic: it currently affects 415 million adults and 642 million are expected to suffer from it by 2040(1).

(1) Source: IDF (International Diabetes Federation) Diabetes Atlas, 7th edition, 2015.
Having worked for many years alongside diabetic patients through innovative treatments and care devices, we have chosen to go one step further in improving the lives of patients, in partnership with Verily (formerly Google Life Science), the expert in applied healthcare technology. The continuous and real-time monitoring of diabetics’ health status—using big data technology—should help control diabetes in a more proactive way and thus reduce the risk of long-term complications. We also take a ethical approach to reducing public health spending.

New technology to support healthcare.

Rheumatoid arthritis affects the joints.

RHEUMATOID ARTHRITIS

NEW HOPE FOR PATIENTS

Rheumatoid arthritis is the most common form of chronic inflammatory arthritis. More common in women and in developed countries, the prevalence of the disease varies between 0.3% and 1% of the population. In partnership with Regeneron, we are currently developing sarilumab for moderate to severe forms of the disease. In 2015, the file was submitted to the US health authorities and a review is expected in the fourth quarter of 2016.